Creo Medical Group PLC (LON:CREO – Get Free Report)’s share price traded up 0.9% on Friday . The stock traded as high as GBX 29.47 ($0.38) and last traded at GBX 29 ($0.38). 75,035 shares were traded during trading, a decline of 88% from the average session volume of 604,553 shares. The stock had previously closed at GBX 28.75 ($0.37).
Creo Medical Group Stock Up 0.9 %
The company has a market cap of £104.92 million, a price-to-earnings ratio of -414.29 and a beta of 0.90. The stock has a 50-day simple moving average of GBX 31.34 and a 200-day simple moving average of GBX 33.98. The company has a current ratio of 3.83, a quick ratio of 2.19 and a debt-to-equity ratio of 13.88.
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Featured Articles
- Five stocks we like better than Creo Medical Group
- How to Read Stock Charts for Beginners
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- MarketBeat Week in Review – 8/19 – 8/23
- Dividend Payout Ratio Calculator
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
